Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947

被引:26
作者
Hasegawa, K
Watanabe, T
Sato, H
Sagane, Y
Mutoh, S
Suzuki, T
Yamano, A
Kouguchi, H
Takeshi, K
Kamaguchi, A
Fujinaga, Y
Oguma, K
Ohyama, T [1 ]
机构
[1] Tokyo Univ Agr, Fac Bioind, Dept Food Sci & Technol, Abashiri 0992493, Japan
[2] Rigaku Corp, Xray Res Lab, Akishima, Tokyo 1968666, Japan
[3] Hokkaido Inst Publ Hlth, Sapporo, Hokkaido 0600819, Japan
[4] Hlth Sci Univ Hokkaido, Sch Dent, Toubetsu 0610293, Japan
[5] Okayama Univ, Sch Med, Dept Bacteriol, Okayama 7008558, Japan
关键词
botulinum neurotoxin; botulinum toxin complex; hemagglutinin; isoelectric point;
D O I
10.1023/B:JOPC.0000039551.42676.4c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A unique strain of Clostridium botulinum, serotype D 4947 (D-4947), produces a considerable amount of a 650 kDa toxin complex (L-TC) and a small amount of a 280 kDa M-TC, a 540 kDa TC, and a 610 kDa TC. The complexes are composed of only un-nicked components, including neurotoxin (NT), nontoxic nonhemagglutinin (NTNHA) and hemagglutinin subcomponents (HA-70, HA-33 and HA-17). Unlike other NTs from all serotype strains, separation of D-4947 NT from L-TC, except for M-TC, during chromatography required highly alkaline conditions around pH 8.8. The separated NT and NTNHA/HAs complex can be reconstituted to L-TC that is indistinguishable from the parent L-TC with respect to toxicity, hemagglutination activity and gel filtration profile. The isoelectric points of NT and NTNHA/HAs were close together depending on the number of HA-33/17 molecules. We have established a new method to separate the unique D-4947 NT from the complex, which will yield valuable information on structure of botulinum toxin.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 21 条
[1]   Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species [J].
Chen, F ;
Kuziemko, GM ;
Stevens, RC .
INFECTION AND IMMUNITY, 1998, 66 (06) :2420-2425
[2]   Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms [J].
Chen, F ;
Kuziemko, GM ;
Amersdorfer, P ;
Wong, C ;
Marks, JD ;
Stevens, RC .
INFECTION AND IMMUNITY, 1997, 65 (05) :1626-1630
[3]   A protease-resistant novel hemagglutinin purified from type A Clostridium botulinum [J].
Fu, FN ;
Sharma, SK ;
Singh, BR .
JOURNAL OF PROTEIN CHEMISTRY, 1998, 17 (01) :53-60
[4]  
Gessler F, 1999, FEMS IMMUNOL MED MIC, V24, P361, DOI 10.1111/j.1574-695X.1999.tb01306.x
[5]   EFFECT OF PH ON THE STABILITY OF TYPE-C TOXIN OF CLOSTRIDIUM-BOTULINUM [J].
HALOUZKA, J ;
HUBALEK, Z .
FOLIA MICROBIOLOGICA, 1992, 37 (02) :157-158
[6]  
KEESER E, 1952, ARZNEIMITTEL-FORSCH, V2, P501
[7]   In vitro reconstitution of the Clostridium botulinum type D progenitor toxin [J].
Kouguchi, H ;
Watanabe, T ;
Sagane, Y ;
Sunagawa, H ;
Ohyama, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) :2650-2656
[8]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[9]   MECHANISM OF ACTION OF TETANUS AND BOTULINUM NEUROTOXINS [J].
MONTECUCCO, C ;
SCHIAVO, G .
MOLECULAR MICROBIOLOGY, 1994, 13 (01) :1-8
[10]   Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components [J].
Mutoh, S ;
Kouguchi, H ;
Sagane, Y ;
Suzuki, T ;
Hasegawa, K ;
Watanabe, T ;
Ohyama, T .
BIOCHEMISTRY, 2003, 42 (37) :10991-10997